NDC 0078-0743

ILEVRO

Nepafenac

ILEVRO is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Nepafenac.

• Product ID: 0078-0743_0cb21156-4f4a-4e49-bc0c-7d2eab045f86
• NDC: 0078-0743
• Product Type: Human Prescription Drug
• Proprietary Name: ILEVRO
• Generic Name: Nepafenac
• Dosage Form: Suspension/ Drops
• Route of Administration: OPHTHALMIC
• Marketing Start Date: 2012-12-20
• Marketing Category: NDA / NDA
• Application Number: NDA203491
• Labeler Name: Novartis Pharmaceuticals Corporation
• Substance Name: NEPAFENAC
• Active Ingredient Strength: 3 mg/mL
• Pharm Classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0078-0743-03

1 BOTTLE in 1 CARTON (0078-0743-03) > 3 mL in 1 BOTTLE

• Marketing Start Date: 2021-01-15
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "ILEVRO" or generic name "Nepafenac"

NDC	Brand Name	Generic Name
0065-1750	ILEVRO	nepafenac
0078-0743	ILEVRO	nepafenac
0065-0002	NEVANAC	nepafenac
0078-0778	NEVANAC	nepafenac